Relative risk and economic consequences of inpatient care among patients with renal failure

Journal of the American Society of Nephrology

Volumn 7, Issue 5, 1996, Pages 751-762

  Thamer, Mae ^a   Ray, Nancy Fox ^a   Fehrenbach, Sheila Nicole ^a   Richard, Christian ^a   Kimmel, Paul L ^b  

^a Med Technol Pract Patterns Inst ^*  (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Attributable costs; Chronic renal failure; ESRD; Hospital costs; Pre ESRD

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC KIDNEY FAILURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; ELECTROLYTE DISTURBANCE; EMPHYSEMA; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEMODIALYSIS; HOSPITALIZATION; HUMAN; HYPERTENSION; INFANT; ISCHEMIC HEART DISEASE; KIDNEY TRANSPLANTATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; SEPSIS; UNITED STATES; UREMIA;

EID: 0030357602     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Kimmel PL. Management of the patient with chronic renal disease. In: Greenberg A, Ed. Primer on Kidney Diseases. San Diego: Academic Press; 1994:281-287.
2. Rettig RA, Levinsky NG, eds. Kidney Failure and the Federal Government. Washington, DC: National Academy Press; 1991.
3. Adams PF, Benson V: Current estimates from the National Health Interview Survey. National Center for Health Statistics. Vital Health Stat 1992;184[Series 10].
4. US Renal Data System. USRDS 1993 Annual Data Report. Washington, DC: The National Institute of Diabetes and Digestive and Kidney Diseases; 1993.
5. National Center for Health Statistics. Annual summary of births, marriages, divorces, and deaths: United States, 1992. Monthly vital statistics report 41 (13). Hyattsville, MD: Public Health Services; 1993.
6. Health Care Financing Administration. Research Report. End Stage Renal Disease, 1992. [HCFA Pub. No. 03359.] Baltimore, MD: Health Care Financing Administration, Office of Research and Demonstrations, September 1994.
7. Jones KR: Factors associated with hospitalization in a sample of chronic hemodialysis patients. Health Serv Res 1991;26:671-699.
8. Smith DG, Harlan LC, Hawthorne VM: The charges for ESRD treatment of diabetics. J Clin Epidemiol 1989;42: 111-118.
9. Levin NW, Webb RL, Held PJ, Wolfe RA, Fitzsimmons SC: Hospitalization among dialysis patients and transplant recipients in the U.S. Am J Kidney Dis 1990;16: 61-64.
10. Eggers PW, Connerton R, McMullan M: The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival. Health Care Financ Rev 1984;5:65-68.
11. Powe NR, Griffiths RI, Watson AJ, et al.: Effect of recombinant erythropoietin on hospital admissions, length of stay and costs of dialysis patients. J Am Soc Nephrol 1994;4:1455-1465.
12. Delano BG: Improvements in quality of life following treatment with r-Hu-EPO in anemic hemodialysis patients. Am J Kidney Dis 1989;14:14-18.
13. Lowrie EG, Laird NM, Parker TF, Sargent JA: Effect of the hemodialysis prescription on patient morbidity. N Engl J Med 1981;305:1176-1181.
14. Chester AC, Rakowski RA, Argy WP, Giacalone D, Schreiner GE: Hemodialysis in the eighth and ninth decades of life. Arch Intern Med 1979;139:1001-1005.
15. Eggers PW. Analysis of indicators of case-mix differences between free-standing facility and hospital-based Medicare ESRD patients. [Working Paper No. OR38.] Baltimore, MD: Health Care Financing Administration, Office of Research and Demonstrations; 1982.
16. Radecki SE, Mendenhall RC, Nissenson AR, et al.: Case-mix and treatment in ESRD: Hemodialysis vs. peritoneal dialysis. Am J Kidney Dis 1988;11:7-14.
17. Bureau of the Census. Statistical Abstract of the United States, 1993. 113th edition. Washington, DC: Department of Commerce; 1993.
18. National Center for Health Statistics. 1991 National Health Interview Survey. Public Use Data Tape. Hyattsville, MD: National Center for Health Statistics, 1993.
19. Ford ES, Herman WH: Leisure-time physical activity patterns in the U.S. diabetic population. Findings from the 1990 National Health Interview Survey - Health Promotion and Disease Prevention Supplement. Diabetes Care 1995:18:27-33.
20. Ford ES, Malarcher AM, Herman WH, Aubert RE: Diabetes mellitus and cigarette smoking. Findings from the 1989 National Health Interview Survey. Diabetes Care 1994;17:688-692.
21. Evaluation of National Health Interview Survey diagnostic reporting. Vital Health Stat 1994;120:1-116.
22. National Center for Health Statistics. 1991 National Hospital Discharge Survey. Public Use Computer Data Tape. Hyattsville, MD: Department of Commerce; 1993.
23. Jones MK, Allen MM, Brouch KL, Aaron WS, Eds. International Classification of Diseases. 9th Revision. Clinical Modification. Alexandria, VA: St. Anthony Publishing, Inc.; 1993.
24. Elixhauser A, Andrews RM, Fox S: Clinical classifications for health policy research: Discharge statistics by principal diagnosis and procedure. [AHCPR Pub. No. 93-0043.] Rockville, MD: Agency for Health Care Policy and Research, Division of Provider Studies Research Note 17; August 1993.
25. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York: John Wiley & Sons; 1981:239-247.
26. Kahn HA, Sempos CT. Statistical Methods in Epidemiology. New York: Oxford University; 1989:72-84.
27. Quality of Care/Medicare Provider Analysis and Review File, 1991. Restricted Use Computer Data Tape. Baltimore, MD: Health Care Financing Administration.
28. Ray N, Wills S, Thamer M. Direct and Indirect Costs of Diabetes in the United States in 1992. Alexandria, VA: American Diabetes Association; 1993.
29. Huse DM, Oster G, Killen AR, Lacey MJ, Colditz GA: The economic costs of non-insulin-dependent diabetes mellitus. JAMA 1989;262:2708-2713.
30. Phillips S, Fox N, Jacobs J, Wright WE: The direct medical costs of osteoporosis for American women aged 45 and older, 1986. Bone 1988;9:271-279.
31. Ray NF, Larsen JW Jr, Stillman RJ, Jacobs J: Economic impact of hospitalizations for lower abdominal adhesiolysis in the United States in 1988. Surg Gynecol Obstet 1993;176:271-276.
32. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research: Principles and Quantitative Methods. Van Nostrand Reinhold Company: New York; 1982.
33. Munda R, First MR, Alexander JW, Linnemann CC, Fidler JP, Kittur D: Polytetrafluoroethylene graft survival in hemodialysis. JAMA 1983;249:219-222.
34. Raju S: PTFE grafts for hemodialysis access. Ann Surg 1987;206:206-266.
35. Bell DD, Rosenthal JJ: Arteriovenous graft life in chronic hemodialysis. Arch Surg 1988;123:1169-1172.
36. Schuman ES, Gross GF, Hayes JF, Standage BA: Long-term patency of polytetrafluoroethylene graft fistulas. Am J Surg 1988;155:644-646.
37. Feldman HI, Held PJ, Hutchinson JT, Stoiber E, Hartigan MF, Berlin JA: Hemodialysis vascular access morbidity in the United States. Kidney Int 1993;43:1091-1096.
38. Waller BF, Palumbo PJ, Roberts WC: Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years: Analysis of 229 diabetic patients with and without clinical evidence of coronary artery disease and comparison to 183 control subjects. Am J Med 1980;69:498-506.
39. Freedman DS, Gruchow HW, Bamrah VS, Anderson AJ, Babboriak JJ: Diabetes mellitus and arteriographically documented coronary artery disease. J Clin Epidemiol 1988;41:659-668.
40. Most RS, Sinnock P: The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 1983;6:87-90.
41. Palumbo PH, Elveback LR, Whisnant JP: Neurologic complications of diabetes mellitus: Transient ischemic attack, stroke, and peripheral neuropathy. Adv Neurol 1978;19:593-601.
42. Herman WH, Teutsch SM. Kidney diseases associated with diabetes, In: Harris MI, Ed. Diabetes in America. Washington, DC: National Institutes of Health; 1985: XIV-1-31.
43. Leslie PJ, Patrick AW, Hepburn DA, Scougal IJ, Frier BM: Hospital inpatient statistics underestimate the morbidity associated with diabetes mellitus. Diabet Med 1992;9:379-385.
44. Finkler SA: The distinction between costs and charges. Ann Int Med 1982;96:102-109.
45. Jacobson HR, Striker GE: Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease. Am J Kidney Dis 1995;25:103-106.
46. National Institutes of Health. Morbidity and Mortality of Dialysis. Consensus development conference statement. Bethesda, MD: National Institutes of Health; 1993.